New York State Common Retirement Fund Oncocyte Corp Transaction History

New York State Common Retirement Fund

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.86 - $1.53 $30,530 - $54,315	-35,500 Reduced 98.41%	573 $1,000
Q4 2021 Feb 02, 2022	SELL	$2.04 - $3.59 $283 - $499	-139 Reduced 0.38%	36,073 $78,000
Q3 2021 Nov 02, 2021	SELL	$3.53 - $5.89 $44,057 - $73,513	-12,481 Reduced 25.63%	36,212 $129,000
Q2 2021 Aug 02, 2021	BUY	$3.77 - $6.0 $2,235 - $3,558	593 Added 1.23%	48,693 $279,000
Q1 2021 May 11, 2021	BUY	$2.39 - $6.5 $20,793 - $56,550	8,700 Added 22.08%	48,100 $250,000
Q2 2020 Aug 07, 2020	BUY	$1.91 - $3.45 $56,154 - $101,430	29,400 Added 294.0%	39,400 $75,000
Q3 2019 Nov 07, 2019	SELL	$1.59 - $2.51 $47,700 - $75,300	-30,000 Reduced 75.0%	10,000 $21,000
Q2 2019 Aug 09, 2019	BUY	$2.49 - $5.45 $99,600 - $218,000	40,000 New	40,000 $100,000
Q2 2018 Aug 10, 2018	SELL	$2.0 - $3.3 $31,400 - $51,810	-15,700 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	15,700	15,700 $82,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $294M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.